Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type 2 diabetes mellitus

Journal of Endocrinological Investigation

Volumn 25, Issue 9, 2002, Pages 779-784

  Matějková Běhanová, Magdalena ^a   Zamrazil, V ^a   Vondra, K ^a   Vrbikova J ^a   Kucera P ^a   Hill, M ^a   Andel M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autoimmune thyroiditis; C peptide; Glutamic acid decarboxylase antibodies; T2DM; TG antibodies; Thyroid peroxidase antibodies

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; ORAL ANTIDIABETIC AGENT; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DIET RESTRICTION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOGRAPHY; FEMALE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DEHYDROGENASE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; THYROIDITIS, AUTOIMMUNE;

EID: 0036796202     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345512     Document Type: Article

References (28)

1. Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20: 1183-1197.
2. Pittman W.B., Acton R.T., Barger B.O. et al. HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty. Diabetes 1982, 31: 122-125.
3. Tuomi T., Groop L.C., Zimmet P., Rowley M.J., Knowles W., Mackay I.R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993, 42: 359-362.
4. Zimmet P., Tuomi T., Mackay I. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diab. Med. 1994, 11: 299-303.
5. Niskanen L.K., Tuomi T., Karjalainen J., Groop L.C., Uusitupa M.I. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995, 18: 1557-1565.
6. Zimmet P., Turner R., McCarty D., Rowley M., Mackay I. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999, 22: B59-B64.
7. Lorini R., d'Annunzio G., Vitali L., Scaramuzza A. IDDM and autoimmune thyroid disease in the paediatric age group. J. Pediatr. Endocrinol. Metab. 1996, 9: 89-94.
8. Hansen D., Bennedbaek F.N., Hansen L.K., Hoier-Madsen M., Jacobsen B.B., Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur. J. Endocrinol. 1999, 140: 512-518.
9. Holl R.W., Bohm B., Loos U., Grabert M., Heinze E., Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes. Effect of age, gender and HLA type. Horm. Res. 1999, 52: 113-118.
10. Radetti G., Paganini C., Gentili L. et al. Frequency of Hashimoto's thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol. 1995, 32: 121-124.
11. Abrams P., De Leeuw I., Vertommen J. Belgian Diabetes Registry. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLADQA1*0301-DQB1*0302. Diabet. Med. 1996, 13: 415-419.
12. Vondra K., Vrbíková J., Ivašková E. et al. Antibodies against thyroglobulin and microsomes in type 1 adult diabetics and their possible clinical impact. Vnitr. Lek. 1996, 42: 767-771.
13. McCanlies E., O'Leary L.A., Foley T.P. et al. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J. Clin. Endocrinol. Metab. 1998, 83: 1548-1551.
14. Gambelunghe G., Forini F., Laureti S. et al. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxf.) 2000, 52: 565-573.
15. Groop L., Miettinen A., Groop P.-H., Meri S., Koskimies S., Bottazzo G.F. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 1988, 37: 99-103.
16. Sostre S., Reyes M.M. Sonographic diagnosis and grading of Hashimoto's thyroiditis. J. Endocrinol. Invest. 1991, 14: 115-121.
17. Pfutzner A., Forst T., Ambrosch A., Schmitz H., Lichtwald K., Beyer J. Determination of antiGAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum. Exp. Clin. Endocrinol. Diabetes 1995, 103: 123-125.
18. The Producer Information: The JDF Combinatorial Auto-antibody Assay Work shop (ICA512/IA2, GAD, ICA, IAA and combinations) on: 14th Immunology of Diabetes Workshop Meeting, 1st Congress of the Immunology of Diabetes Society, 31st October - 3rd November, Italy.
19. Fernandez-Castaner M., Molina A., Lopez-Jimenes L., Gomez J.M., Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care 1999, 22: 377-381.
20. Amino N. Antithyroid antibodies. In: Ingber S.H., Braverman L.E. (Eds.), The Thyroid (ed. 5). JB Lippincott, Philadelphia, 1986, p. 546.
21. Okayasu I., Hatakeyama S., Tanaka Y., Sakurai T., Hoshi K., Lewis P.D. Is focal chronic autoimmune thyroiditis an age-related disease? Differences in incidence and severity between Japanese and British. J. Pathol. 1991, 163: 257-264.
22. Okayasu I., Hara Y., Nakamura K., Rose N.R. Racial and age-related differences in indicidence and severity autoimmune thyroiditis. Am. J. Clin. Pathol. 1994, 101: 698-702.
23. Prentice L.M., Phillips D.I., Sarsero D., Beever K., McLachlan S.M., Smith B.R. Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol. (Copenh.) 1990, 123: 493-498.
24. Čerovská J., Bílek R., Čermáková I., et al. Prevalence of thyroid functional and morphological disorders and iodine urinary excretion in inhabitants of 10 regions of Czech Republic. Medica Revue 2001, 8: 37-41.
25. Pedersen O.M., Aaardal N.P., Larssen T.B., Varhaugh J.E., Myking O., Vi Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 2000, 10: 251-259.
26. Tuomi T., Carlson A.L., Li H., et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999, 48: 150-157.
27. Chiovato L., Mariotti S., Pinchera A. Thyroid disease in the elderly. Baillieres Clin. Endocrinol. Metab. 1997, 11: 251-270.
28. Förster G., Krummenauer F., Kühn I., Beyer J., Kahaly G. Polyglandular autoimmune syndrome type II: epidemiology and form of manifestation. Dtsch. Med. Wochenschr. 1999, 124: 1476-1481.